CVS/Coram Infusion Deal Is a Good Prescription for Investors
The CVS Caremark acquisition of Coram is a good deal for investors.
CVS Caremark's Big Thanksgiving Purchase: The Coram Buyout
The oft-overlooked home infusion and alternative site infusion market represents a huge opportunity for CVS Caremark with its recent acquisition of leading infusion provider Coram Specialty Infusion Services.
Will Rite Aid Continue to Heat Up?
Will Rite Aid’s stock continue to rise? How is the company doing compared to its peers including Walgreen and CVS Caremark?